Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Gang Nie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-3304-4793; OpenAlex author ID A5062833363. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: none · 2025: 2 papers

Papers 4

  1. A mitochondria-related gene-based signature predicts pancreatic ductal adenocarcinoma clinical outcome and revealed CAMK2A/THEM4 regulates progression phenotyp… Co-author DOI 10.1186/s12967-025-07456-5↗
  2. KAT8 catalyzes the acetylation of SEPP1 at lysine 247/249 and modulates the activity of CD8+ T cells via LRP8 to promote anti-tumor immunity in pancreatic canc… First author DOI 10.1186/s13578-025-01356-3↗
  3. UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation. First author DOI 10.21037/jgo-22-516↗
  4. Integrative analysis of metabolome and gut microbiota in Patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/jca.52943↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhongfei Zhu · 2 shared papers, 2025 · strength 0.61
  2. Gang Jin · 2 shared papers, 2022–2025 · strength 0.46
  3. Dan Ding · 1 shared paper, 2025 · strength 0.33
  4. Xiaobo Peng · 1 shared paper, 2025 · strength 0.33
  5. Xianbao Zhan · 1 shared paper, 2025 · strength 0.33
  6. Xiaoyi Yin · 1 shared paper, 2025 · strength 0.28
  7. Xiaohan Shi · 1 shared paper, 2025 · strength 0.28
  8. Xiaodong Guo · 1 shared paper, 2022 · strength 0.17
  9. Xuan Liu · 1 shared paper, 2022 · strength 0.17
  10. Jingzhu Cao · 1 shared paper, 2022 · strength 0.16
  11. Chenming Ni · 1 shared paper, 2022 · strength 0.16
  12. Liu Ouyang · 1 shared paper, 2022 · strength 0.16
  13. Hao Hu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.